Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.3x | −2.4x | −0.2x | |
PEG Ratio | −0.25 | −0.06 | 0.00 | |
Price/Book | 17.0x | 2.8x | 2.6x | |
Price / LTM Sales | 129.7x | 1.8x | 2.8x | |
Upside (Analyst Target) | 197.3% | 100.0% | 65.6% | |
Fair Value Upside | Unlock | 27.3% | 10.0% | Unlock |
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.